Skip to main navigation
Logo
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance and Compliance
    • Corporate Governance
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Overview
    • SEC Filings
    • Annuals and Proxies
  • Investor Contact

Committee Composition

Audit Nominating and Corporate Governance Compensation
Scott D. Myers, MBA
Francis R. Cano, Ph.D. Nominating and Corporate Governance
Julie Eastland Audit
Andrew Hack, M.D., Ph.D Audit
Daniel L. Kisner, M.D. Nominating and Corporate Governance Compensation
Brent MacGregor Nominating and Corporate Governance
Peggy V. Phillips Audit Compensation
Natale Ricciardi Compensation
= Chairperson = Member = Chairman of the Board

Shareholder Tools

Footer Links - Column 1

  • About
  • Overview
  • Management
  • Board of Directors
  • Dynavax Europe

Footer Links - Column 2

  • Science
  • Overview
  • Publications & Presentations
  • CpG 1018

Footer Links - Column 3

  • Careers
  • Join Our Team
  • Values
  • Job Opportunities
  • Benefits

Footer Links - Column 4

  • Investors
  • Overview
  • News & Events
  • Stock Information
  • Financials
  • Contact Us

Footer Links - Column 5

  • Product
  • HEPLISAV-B

Footer Links - Column 6

  • Pipeline
  • Clinical Trials

Footer Links - Column 7

  • Contact

GP - Contact IR Footer

  • Investor Contact

    Nicole Arndt
    Investor Relations
    narndt@dynavax.com

Legal Links

  • Terms & Conditions
  • Privacy Notice
  • © 2023 Dynavax Technologies Corporation. All rights reserved.